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assessment of only non–Q-wave MIs, which dates from a period
when the non–Q wave MI was assumed to be a valid subset with
unique characteristics. It is to be hoped that this misconception has
been permanently put to rest and, further, that investigations of
outcome after MI will avoid the egregious error of combining
random mixtures of first and subsequent infarcts.
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Does Flow Reserve Match Contractility?
I have read with great interest the report by Barilla` et al. (1). The
data reported are intriguing because, to the best of my knowledge,
this is the first report indicating that the restoration of regional
contractility during low dose dobutamine administration may
occur despite different perfusion patterns, depending on the
presence or absence of collateral filling.
Let me raise an issue not addressed in the Discussion of Barilla`’s
article. I definitely agree with Bonow (2) that the increase in flow
in patients with collateral filling is expected, because the drop of
pressure beyond the fixed obstruction can increase the flow, despite
the coronary driving pressure’s being unchanged. The no-
measurable-flow response in patients without collateral channels
can also be expected. In fact, why should the flow increase through
a stenosis or an occlusion? Irrespective of flow regimen, the authors
(1) noted an amelioration in contractility of dysfunctional myocar-
dium—one that was still present at 2-methoxy-isobutyl-isonitrile
(MIBI) administration and during the time allowed for it to
distribute to the myocardium (i.e., up to 8 min), I presume,
because no mention was ever made to subsequent deterioration of
wall motion. This is an astonishingly long time, which would more
appropriately define the response to low dose dobutamine of
stunned myocardium (but this was not the case, as indicated by the
low sestamibi uptake). It seems inconceivable that such a pro-
longed increase in contractility may occur in the absence of an
adequate increase in blood flow, the situation being absolutely
different from the postextrasystolic potentiation of contractility,
when myocytes burn their energy stores all in one go. By contrast,
the increase in contractility of ischemic but viable myocardium at
low dose dobutamine is a short-lived phenomenon: it may begin at
very low dosage (as low as 2.5 mg/kg body weight per min, in our
experience) and usually fades away at 10 mg/kg per min, seldom at
20 mg/kg per min. In patients with very severe coronary stenosis or
coronary occlusion without collateral blood filling, a biphasic
response to dobutamine should be expected at a dosage even lower
than that at which the authors injected technetium-99m sestamibi.
Given this, as well as the notion of the ischemic cascade (3,4), I
make the point that Barilla` et al. (1) described an intermediate
phase of the biphasic response phenomenon—that is, the time
when the flow reserve is exhausted, but wall contractility has not
yet deteriorated in response to forthcoming or ongoing ischemia,
or both. I suggest that this possibility is whispered to the reader.
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REPLY
We are grateful to Dr. Barletta for his comments. Obviously, the
findings we have reported constitute an intermediate step of a
biphasic response phenomenon, as stated by Dr. Barletta. How-
ever, a 5-min step protocol for low dose dobutamine echocardi-
ography is common (1,2), and a biphasic response (i.e., wall
motion improvement followed by worsening) is rarely observed at
low doses of 5 to 10 mg/kg body weight per min (3). Nevertheless,
no change in wall motion and thickening occurred during the
3 min after tracer injection, even when we used 10 mg/kg per min
of dobutamine.
We also wish to emphasize that our study was not intended to
describe the behavior of inotropic contractile reserve during low
dose dobutamine infusion, but it was aimed at investigating the
pathophysiologic and clinical implications of the presumed mis-
match between perfusion and contractility in areas with severely
hypoperfused viable myocardium.
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